Laar, M.A.F.J. van de

patient pylori eradication nsaid study group ulcer pylori eradication placebo group placebo helicobacter eradication group therapy gastriti treatment e ffect helicobacter pylori helicobacter pylori infection gastroprotective gastroduodenal nsaid treatment disease gastroduodenal ulcers nsaid users corpus flammatory number trial center month antrum randomized pylori eradication therapy eradication therapy signi leest arthritis atrophy infection gastroprotective drugs helicobacter pylori eradication result score anti-in erosion vu university study medication nonsteroidal table dyspepsia flammation metaplasia effect baseline rheumatology biopsy incidence endoscopy omeprazole 20 mg 12 months signi ficant differences university difference ficant nsaid therapy author coxib publishing health fference gastroenterol presence di fferences journal compilation event histology gastroprotective agents blackwell endoscopic